Goldman Sachs’s Tyra Biosciences TYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.01M | Buy |
105,595
+27,589
| +35% | +$264K | ﹤0.01% | 3836 |
|
|
2025
Q1 | $725K | Buy |
78,006
+13,896
| +22% | +$129K | ﹤0.01% | 4029 |
|
|
2024
Q4 | $891K | Sell |
64,110
-24,971
| -28% | -$347K | ﹤0.01% | 3983 |
|
|
2024
Q3 | $2.09M | Sell |
89,081
-25,793
| -22% | -$606K | ﹤0.01% | 3343 |
|
|
2024
Q2 | $1.84M | Buy |
114,874
+100,797
| +716% | +$1.61M | ﹤0.01% | 3237 |
|
|
2024
Q1 | $231K | Buy |
+14,077
| New | +$231K | ﹤0.01% | 4289 |
|
|
2021
Q4 | – | Sell |
-207,283
| Closed | -$3.65M | – | 5687 |
|
|
2021
Q3 | $3.65M | Buy |
+207,283
| New | +$3.65M | ﹤0.01% | 3008 |
|